Claudiu Morgovan
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 2
-
- RNA Interference and Gene Delivery 2
- Co-authors
- Luca Liviu Rus (26 shared papers)Anca Maria Juncan (18 shared papers)Andreea Loredana Vonica-Țincu (18 shared papers)Felicia Gabriela Gligor (32 shared papers)Anca Maria Arseniu (20 shared papers)Carmen Maximiliana Dobrea (27 shared papers)Adina Frum (26 shared papers)Adriana Aurelia Chiş (17 shared papers)
- Journals
- Pharmaceuticals (9 papers)Biomedicines (4 papers)Pharmaceutics (3 papers)Molecules (3 papers)Journal of Clinical Medicine (3 papers)
- Partner nations
- RomaniaFranceNew Zealand
In The Last Decade
Claudiu Morgovan
49 papers receiving 992 citations
Claudiu Morgovan's Hit Papers
Peers
Comparison fields: 5 of 139
- Biomaterials 163
- Pharmaceutical Science 70
- Molecular Medicine 52
- Dermatology 86
- Applied Microbiology and Biotechnology 19
Countries citing papers authored by Claudiu Morgovan
This map shows the geographic impact of Claudiu Morgovan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudiu Morgovan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudiu Morgovan more than expected).
Fields of papers citing papers by Claudiu Morgovan
This network shows the impact of papers produced by Claudiu Morgovan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudiu Morgovan. The network helps show where Claudiu Morgovan may publish in the future.
Co-authors
The 25 scholars most cited alongside Claudiu Morgovan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Applications and Limitations of Dendrimers in Biomedicine Hit paper breakdown → | 2020 | 314 |
| 2 | Advantages of Hyaluronic Acid and Its Combination with Other Bioactive Ingredients in Cosmeceuticals Hit paper breakdown → | 2021 | 229 |
| 3 | 2022 | 62 | |
| 4 | 2020 | 35 | |
| 5 | 2022 | 25 | |
| 6 | 2021 | 24 | |
| 7 | 2020 | 20 | |
| 8 | 2024 | 20 | |
| 9 | 2022 | 20 | |
| 10 | 2019 | 20 | |
| 11 | 2024 | 19 | |
| 12 | 2019 | 19 | |
| 13 | 2023 | 18 | |
| 14 | 2020 | 17 | |
| 15 | 2022 | 17 | |
| 16 | 2024 | 17 | |
| 17 | 2021 | 16 | |
| 18 | 2023 | 15 | |
| 19 | 2023 | 12 | |
| 20 | 2023 | 10 |
About Claudiu Morgovan
Claudiu Morgovan is a scholar working on Pharmacology, Molecular Biology, Endocrinology, Diabetes and Metabolism, Oncology and Toxicology, having authored 55 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Diabetes Treatment and Management (3 papers), Skin Protection and Aging (3 papers), RNA Interference and Gene Delivery (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Pharmaceutical Economics and Policy (2 papers). The work is most often cited by research in Biomaterials (163 citations), Pharmaceutical Science (70 citations), Molecular Medicine (52 citations), Dermatology (86 citations) and Applied Microbiology and Biotechnology (19 citations). Claudiu Morgovan has collaborated with scholars based in Romania, France and New Zealand. Frequent co-authors include Luca Liviu Rus, Anca Maria Juncan, Andreea Loredana Vonica-Țincu, Felicia Gabriela Gligor, Anca Maria Arseniu, Carmen Maximiliana Dobrea, Adina Frum, Adriana Aurelia Chiş, Anca Butucă and Felicia Loghin. Their work appears in journals such as Pharmaceuticals, Biomedicines, Pharmaceutics, Molecules and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.